Elutia ELUT
NASDAQ ELUT
$0.94 +0.00 (+0.24%)
As of: Nov 11, 2026 · 10:58 AM EST

Elutia (ELUT) Non-Current Deferred Revenue (2019 - 2021)

Updated

Elutia's Non-Current Deffered Revenue was $936,000 in Q3 2021, up 77.6% from $527,000 a year earlier and up 7.6% from the prior quarter.

Analysis

Elutia (ELUT) Non-Current Deferred Revenue (2019 - 2021) Analysis & Trends

At the end of FY2020, Non-Current Deffered Revenue at Elutia came in at $756,000, up 7.2% from FY2019.

  • In earlier years, Non-Current Deffered Revenue was $705,000 in FY2019.
  • Per Business Quant data, ELUT's Non-Current Deffered Revenue in the three quarters before Q3 2021 was $870,000 (Q2 2021), $830,000 (Q1 2021) and $756,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Elutia 41.29 Mn -72.54 Mn 702,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 936,000.00
Jun 30, 2021 870,000.00
Mar 31, 2021 830,000.00
Dec 31, 2020 756,000.00
Sep 30, 2020 527,000.00
Dec 31, 2019 705,000.00
API Access

Elutia Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ELUT&period=max&api_key=YOUR_API_KEY